Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RINCON RESOURCES LIMITED Proxy Solicitation & Information Statement 2022

May 19, 2022

65672_rns_2022-05-19_629087b6-afeb-4e40-a63c-92f4ab92dd2c.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [126 x 46] intentionally omitted <==

RINCON RESOURCES LIMITED ACN 628 003 538

NOTICE OF GENERAL MEETING

Notice is given that the Meeting will be held at:

TIME : 10:00am (WST) DATE : 22 June 2022 PLACE : Unit 8 1200 Hay Street WEST PERTH WA 6005

The business of the Meeting affects your shareholding and your vote is important.

This Notice of Meeting should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisers prior to voting.

The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at 5:00pm (WST) on 20 June 2022.

BUSINESS OF THE MEETING

AGENDA

1. RESOLUTION 1 – RATIFICATION OF PRIOR ISSUE OF ADVISOR OPTIONS

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 2,500,000 Options on the terms and conditions set out in the Explanatory Statement.”

A voting exclusion statement applies to this Resolution. Please see below.

2. RESOLUTION 2 – APPROVAL TO ISSUE PERFORMANCE OPTIONS

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the Company to issue up to 2,500,000 Options on the terms and conditions set out in the Explanatory Statement.”

A voting exclusion statement applies to this Resolution. Please see below.

3. RESOLUTION 3 – ISSUE OF PERFORMANCE RIGHTS TO RELATED PARTY – BLAIR SERGEANT

To consider and, if thought fit, to pass, the following resolution as an ordinary resolution :

“That, for the purposes of section 195(4) and section 208 of the Corporations Act, Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue 1,000,000 Performance Rights to Mr Blair Sergeant (or his nominee) on the terms and conditions set out in the Explanatory Statement.”

A voting exclusion statement and voting prohibition statement applies to this Resolution. Please see below.

4. RESOLUTION 4 – ISSUE OF PERFORMANCE RIGHTS TO RELATED PARTY – GARY HARVEY

To consider and, if thought fit, to pass, the following resolution as an ordinary resolution :

“That, for the purposes of section 195(4) and section 208 of the Corporations Act, Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue 1,500,000 Performance Rights to Mr Gary Harvey (or his nominee) on the terms and conditions set out in the Explanatory Statement.”

A voting exclusion statement and voting prohibition statement applies to this Resolution. Please see below.

2

4881-04/2951534_4

5. RESOLUTION 5 – ISSUE OF PERFORMANCE RIGHTS TO RELATED PARTY – CAROLINE KEATS

To consider and, if thought fit, to pass, the following resolution as an ordinary resolution :

“That, for the purposes of section 195(4) and section 208 of the Corporations Act, Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue 1,000,000 Performance Rights to Ms Caroline Keats (or her nominee) on the terms and conditions set out in the Explanatory Statement.”

A voting exclusion statement and voting prohibition statement applies to this Resolution. Please see below.

Dated: 20 May 2022

By order of the Board

==> picture [93 x 55] intentionally omitted <==

Victor Goh Company Secretary Rincon Resources Limited

3

4881-04/2951534_4

Voting Prohibition Statements

Resolution 3 – Issue of
Performance Rights to
Related Party
In accordance with section 224 of the Corporations Act, a vote on this
Resolution must not be cast (in any capacity) by or on behalf of a related
party of the Company to whom the Resolution would permit a financial
benefit to be given, or an associate of such a related party (Resolution 3
Excluded Party). However, the above prohibition does not apply if the
vote is cast by a person as proxy appointed by writing that specifies how
the proxy is to vote on the Resolution and it is not cast on behalf of a
Resolution 3 Excluded Party.
In accordance with section 250BD of the Corporations Act, a person
appointed as a proxy must not vote, on the basis of that appointment, on
this Resolution if:
(a)
the proxy is either:
(i) a member of the Key Management Personnel; or
(ii) a Closely Related Party of such a member; and
(b)
the appointment does not specify the way the proxy is to vote on
this Resolution.
Provided the Chair is not a Resolution 3 Excluded Party, the above
prohibition does not apply if:
(a)
the proxy is the Chair; and
(b)
the appointment expressly authorises the Chair to exercise the proxy
even though this Resolution is connected directly or indirectly with
remuneration of a member of the Key Management Personnel.
Resolution 4 – Issue of
Performance Rights to
Related Party
In accordance with section 224 of the Corporations Act, a vote on this
Resolution must not be cast (in any capacity) by or on behalf of a related
party of the Company to whom the Resolution would permit a financial
benefit to be given, or an associate of such a related party (Resolution 4
Excluded Party). However, the above prohibition does not apply if the
vote is cast by a person as proxy appointed by writing that specifies how
the proxy is to vote on the Resolution and it is not cast on behalf of a
Resolution 4 Excluded Party.
In accordance with section 250BD of the Corporations Act, a person
appointed as a proxy must not vote, on the basis of that appointment, on
this Resolution if:
(a)
the proxy is either:
(i) a member of the Key Management Personnel; or
(ii) a Closely Related Party of such a member; and
(b)
the appointment does not specify the way the proxy is to vote on
this Resolution.
Provided the Chair is not a Resolution 4 Excluded Party, the above
prohibition does not apply if:
(a)
the proxy is the Chair; and
(b)
the appointment expressly authorises the Chair to exercise the proxy
even though this Resolution is connected directly or indirectly with
remuneration of a member of the Key Management Personnel.

4

4881-04/2951534_4

Resolution 5 – Issue of
Performance Rights to
Related Party
In accordance with section 224 of the Corporations Act, a vote on this
Resolution must not be cast (in any capacity) by or on behalf of a related
party of the Company to whom the Resolution would permit a financial
benefit to be given, or an associate of such a related party (Resolution 5
Excluded Party). However, the above prohibition does not apply if the
vote is cast by a person as proxy appointed by writing that specifies how
the proxy is to vote on the Resolution and it is not cast on behalf of a
Resolution 5 Excluded Party.
In accordance with section 250BD of the Corporations Act, a person
appointed as a proxy must not vote, on the basis of that appointment, on
this Resolution if:
(a)
the proxy is either:
(i) a member of the Key Management Personnel; or
(ii) a Closely Related Party of such a member; and
(b)
the appointment does not specify the way the proxy is to vote on
this Resolution.
Provided the Chair is not a Resolution 5 Excluded Party, the above
prohibition does not apply if:
(a)
the proxy is the Chair; and
(b)
the appointment expressly authorises the Chair to exercise the proxy
even though this Resolution is connected directly or indirectly with
remuneration of a member of the Key Management Personnel.

Voting Exclusion Statements

In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour of the resolution set out below by or on behalf of the following persons:

Resolution 1 – Ratification
of prior issue of Advisor
Options
A person who participated in the issue or is a counterparty to the
agreement being approved (namely Prenzler) or an associate of that
person or thosepersons.
Resolution 2 – Approval to
issue Performance Options
A person who is expected to participate in, or who will obtain a material
benefit as a result of, the proposed issue (except a benefit solely by
reason of being a holder of ordinary securities in the Company) (namely
Prenzler)or an associate of thatperson(or thosepersons).
Resolution 3 – Issue of
Performance Rights to
Related Party – Blair
Sergeant
Mr Blair Sergeant (or his nominee) and any other person who will obtain a
material benefit as a result of the issue of the securities (except a benefit
solely by reason of being a holder of ordinary securities in the Company)
or an associate of thatperson or thosepersons.
Resolution 4 – Issue of
Performance Rights to
Related Party – Gary
Harvey
Mr Gary Harvey (or his nominee) and any other person who will obtain a
material benefit as a result of the issue of the securities (except a benefit
solely by reason of being a holder of ordinary securities in the Company)
or an associate of thatperson or thosepersons.
Resolution 5 – Issue of
Performance Rights to
Related Party – Caroline
Keats
Ms Caroline Keats (or her nominee) and any other person who will obtain
a material benefit as a result of the issue of the securities (except a
benefit solely by reason of being a holder of ordinary securities in the
Company)or an associate of thatperson or thosepersons.

However, this does not apply to a vote cast in favour of the Resolution by:

  • (a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with the directions given to the proxy or attorney to vote on the Resolution in that way; or

  • (b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

5

4881-04/2951534_4

  • (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the resolution; and

  • (ii) the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

Voting by proxy

To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in accordance with the instructions set out on the Proxy Form.

In accordance with section 249L of the Corporations Act, Shareholders are advised that:

  • each Shareholder has a right to appoint a proxy;

  • the proxy need not be a Shareholder of the Company; and

  • a Shareholder who is entitled to cast two (2) or more votes may appoint two (2) proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If the member appoints two (2) proxies and the appointment does not specify the proportion or number of the member’s votes, then in accordance with section 249X(3) of the Corporations Act, each proxy may exercise one-half of the votes.

Shareholders and their proxies should be aware that:

  • if proxy holders vote, they must cast all directed proxies as directed; and

  • any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies as directed.

Voting in person

To vote in person, attend the Meeting at the time, date and place set out above.

You may still attend the meeting and vote in person even if you have appointed a proxy. If you have previously submitted a Proxy Form, your attendance will not revoke your proxy appointment unless you actually vote at the meeting for which the proxy is proposed to be used, in which case, the proxy’s appointment is deemed to be revoked with respect to voting on that resolution.

Please bring your personalised Proxy Form with you as it will help you to register your attendance at the meeting. If you do not bring your Proxy Form with you, you can still attend the meeting but representatives from Automic will need to verify your identity. You can register from 9:30am (WST) on the day of the meeting.

Should you wish to discuss the matters in this Notice of Meeting please do not hesitate to contact the Company Secretary on +61 8 6555 2950.

6

4881-04/2951534_4

EXPLANATORY STATEMENT

This Explanatory Statement has been prepared to provide information which the Directors believe to be material to Shareholders in deciding whether or not to pass the Resolutions.

1. BACKGROUND TO RESOLUTIONS 1 AND 2

As announced on 8 March 2022, the Company has entered into a marketing and promotional services mandate ( Mandate ) with Prenzler Group Pty Ltd ( Prenzler ) dated 28 February 2022 pursuant to which Prenzler will provide investor relations advice and services to the Company in return for the payment of the following fees:

  • (a) $5,000 per calendar month for the 6 month duration of the contract ( Term ); and

  • (b) where the Company undertakes a capital raising during the Term, the Company will pay Prenzler a fee of 6% of the amount raised ( Capital Raising Fee ). Prenzler will pay any fees to other brokers, co-managers, intermediaries and investors out of the Capital Raising Fee.

In addition, the Company agreed to issue to Prenzler (or its nominees) a total of 5,000,000 Options exercisable at $0.20 expiring 3 years from the date of issue, as follows:

  • (a) 2,500,000 of these Options will vest and be exercisable on and from issue ( Advisor Options ). The Company issued the Advisor Options to Prenzler on 30 March 2022 under its 7.1 placement capacity; and

  • (b) 2,500,000 of these Options ( Performance Options ) will vest on the Company raising a total of at least $2,000,000 of additional capital at a price of more than $0.20 per Share by 28 August 2022 ( Milestone ).

Resolution 1 seeks Shareholder ratification pursuant to Listing Rule 7.4 for the issue of the Advisor Options.

Resolution 2 seeks Shareholder approval for the purposes of Listing Rule 7.1 for the issue of the Performance Options.

2. RESOLUTION 1 – RATIFICATION OF PRIOR ISSUE OF ADVISOR OPTIONS

2.1 General

As set out in Section 1, on 30 March 2022, the Company issued 2,500,000 Advisor Options to Prenzler under its 7.1 placement capacity.

Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity securities that a listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid ordinary securities it had on issue at the start of that 12 month period.

The issue of the Advisor Options does not fit within any of the exceptions set out in Listing Rule 7.2 and, as it has not yet been approved by Shareholders, it effectively uses up part of the 15% limit in Listing Rule 7.1, reducing the Company’s capacity to issue further equity securities without Shareholder

7

4881-04/2951534_4

approval under Listing Rule 7.1 for the 12 month period following the date of issue of the Advisor Options.

Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of equity securities after it has been made or agreed to be made. If they do, the issue is taken to have been approved under Listing Rule 7.1 and so does not reduce the company’s capacity to issue further equity securities without shareholder approval under that rule.

The Company wishes to retain as much flexibility as possible to issue additional equity securities in the future without having to obtain Shareholder approval for such issues under Listing Rule 7.1. Accordingly, the Company is seeking Shareholder ratification pursuant to Listing Rule 7.4 for the issue of the Advisor Options.

Resolution 1 seeks Shareholder ratification pursuant to Listing Rule 7.4 for the issue of the Advisor Options.

2.2 Technical information required by Listing Rule 14.1A

If Resolution 1 is passed, the Advisor Options will be excluded in calculating the Company’s 15% limit in Listing Rule 7.1, effectively increasing the number of equity securities the Company can issue without Shareholder approval over the 12 month period following the date of issue of the Advisor Options.

If Resolution 1 is not passed, the Advisor Options will be included in calculating the Company’s 15% limit in Listing Rule 7.1, effectively decreasing the number of equity securities that the Company can issue without Shareholder approval over the 12 month period following the date of issue of the Advisor Options.

2.3 Technical information required by Listing Rule 7.5

Pursuant to and in accordance with Listing Rule 7.5, the following information is provided in relation to Resolution 1:

  • (a) the Advisor Options were issued to Prenzler;

  • (b) in accordance with paragraph 7.4 of ASX Guidance Note 21, the Company confirms that none of the recipients were:

  • (i) related parties of the Company, members of the Company’s Key Management Personnel, substantial holders of the Company, advisers of the Company or an associate of any of these parties; and

  • (ii) issued more than 1% of the issued capital of the Company;

  • (c) 2,500,000 Advisor Options were issued and the Advisor Options were issued on the terms and conditions set out in Schedule 1;

  • (d) the Advisor Options were issued on 30 March 2022;

  • (e) the Advisor Options were issued at a nil issue price, in consideration for investor relations advice and services provided by Prenzler. The Company has not and will not receive any other consideration for the issue of the Advisor Options (other than in respect of funds received on exercise of the Advisor Options);

8

4881-04/2951534_4

  • (f) the purpose of the issue of the Advisor Options was to satisfy the Company’s obligations under the Mandate; and

  • (g) the Advisor Options were issued to Prenzler under the Mandate. A summary of the material terms of the Mandate is set out in Section 1.

3. RESOLUTION 2 – APPROVAL TO ISSUE PERFORMANCE OPTIONS

3.1 General

As set out in Section 1, the Company is proposing to issue 2,500,000 Performance Options to Prenzler under the Mandate.

As summarised in Section 2.1 above, Listing Rule 7.1 limits the amount of equity securities that a listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid ordinary shares it had on issue at the start of that period.

The proposed issue of the Performance Options does not fit within any of the exceptions set out in Listing Rule 7.2. While the issue does not exceed the 15% limit in Listing Rule 7.1 and can therefore be made without breaching that rule, the Company wishes to retain as much flexibility as possible to issue additional equity securities in the future without having to obtain Shareholder approval under Listing Rule 7.1. Accordingly, the Company is seeking Shareholder approval pursuant to Listing Rule 7.1 so that it does not use up any of its 15% placement capacity under Listing Rule 7.1.

3.2 Technical information required by Listing Rule 14.1A

If Resolution 2 is passed, the Company will be able to proceed with the issue of the Performance Options. In addition, the issue of the Performance Options will be excluded from the calculation of the number of equity securities that the Company can issue without Shareholder approval under Listing Rule 7.1.

If Resolution 2 is not passed, the issue of the Performance Options can still proceed but it will reduce, to that extent, the Company’s capacity to issue equity securities without Shareholder approval under Listing Rule 7.1 for 12 months following the issue.

Resolution 2 seeks Shareholder approval for the purposes of Listing Rule 7.1 for the issue of the Performance Options.

3.3 Technical information required by Listing Rule 7.1

Pursuant to and in accordance with Listing Rule 7.3, the following information is provided in relation to Resolution 2:

  • (a) the Performance Options will be issued to Prenzler;

  • (b) in accordance with paragraph 7.2 of ASX Guidance Note 21, the Company confirms that none of the recipients will be:

  • (i) related parties of the Company, members of the Company’s Key Management Personnel, substantial holders of the Company, advisers of the Company or an associate of any of these parties; and

  • (ii) issued more than 1% of the issued capital of the Company;

9

4881-04/2951534_4

  • (c) the maximum number of Performance Options to be issued is 2,500,000. The terms and conditions of the Performance Options are set out in Schedule 2;

  • (d) the Performance Options will be issued no later than 3 months after the date of the Meeting (or such later date to the extent permitted by any ASX waiver or modification of the Listing Rules) and it is intended that issue of the Performance Options will occur on the same date;

  • (e) the Performance Options will be issued at a nil issue price, in consideration for investor relations advice and services provided by Prenzler;

  • (f) the purpose of the issue of the Performance Options is to satisfy the Company’s obligations under the Mandate;

  • (g) the Performance Options are being issued to Prenzler under the Mandate. A summary of the material terms of the Mandate is set out in Section 1; and

  • (h) the Performance Options are not being issued under, or to fund, a reverse takeover.

4. RESOLUTIONS 3 TO 5 – ISSUE OF PERFORMANCE RIGHTS TO RELATED PARTIES

4.1 General

The Company has agreed, subject to obtaining Shareholder approval, to issue an aggregate of 3,500,000 Performance Rights ( Performance Rights ) to Mr Blair Sergeant, Mr Gary Harvey and Ms Caroline Keats (or their nominees) ( Related Parties ) on the terms and conditions set out below.

Resolutions 3 to 5 seek Shareholder approval for the issue of the Performance Rights to the Related Parties.

4.2 Chapter 2E of the Corporations Act

For a public company, or an entity that the public company controls, to give a financial benefit to a related party of the public company, the public company or entity must:

  • (a) obtain the approval of the public company’s members in the manner set out in sections 217 to 227 of the Corporations Act; and

  • (b) give the benefit within 15 months following such approval,

unless the giving of the financial benefit falls within an exception set out in sections 210 to 216 of the Corporations Act.

The issue of Performance Rights to the Related Parties constitutes giving a financial benefit and each of the Related Parties is a related party of the Company by virtue of being a Director.

As the Performance Rights are proposed to be issued to all of the Directors, the Directors are unable to form a quorum to consider whether one of the exceptions set out in sections 210 to 216 of the Corporations Act applies to the issue of the Performance Rights. Accordingly, Shareholder approval for the issue

10

4881-04/2951534_4

of Performance Rights to the Related Parties is sought in accordance with Chapter 2E of the Corporations Act.

4.3

Listing Rule 10.11

Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a listed company must not issue or agree to issue equity securities to:

  • 10.11.1 a related party;

  • 10.11.2 a person who is, or was at any time in the 6 months before the issue or agreement, a substantial (30%+) holder in the company;

  • 10.11.3 a person who is, or was at any time in the 6 months before the issue or agreement, a substantial (10%+) holder in the company and who has nominated a director to the board of the company pursuant to a relevant agreement which gives them a right or expectation to do so;

  • 10.11.4 an associate of a person referred to in Listing Rules 10.11.1 to 10.11.3; or

  • 10.11.5 a person whose relationship with the company or a person referred to in Listing Rules 10.11.1 to 10.11.4 is such that, in ASX’s opinion, the issue or agreement should be approved by its shareholders,

unless it obtains the approval of its shareholders.

The issue of Performance Rights falls within Listing Rule 10.11.1 and does not fall within any of the exceptions in Listing Rule 10.12. It therefore requires the approval of Shareholders under Listing Rule 10.11.

Resolutions 3 to 5 seek the required Shareholder approval for the issue of the Performance Rights under and for the purposes of Chapter 2E of the Corporations Act and Listing Rule 10.11.

4.4 Technical information required by Listing Rule 14.1A

If Resolutions 3 to 5 are passed, the Company will be able to proceed with the issue of the Performance Rights to the Related Parties within one month after the date of the Meeting (or such later date as permitted by any ASX waiver or modification of the Listing Rules). As approval pursuant to Listing Rule 7.1 is not required for the issue of the Performance Rights (because approval is being obtained under Listing Rule 10.11), the issue of the Performance Rights will not use up any of the Company’s 15% annual placement capacity.

If Resolutions 3 to 5 are not passed, the Company will not be able to proceed with the issue of the Performance Rights and the Company would need to consider alternatives for the Related Parties’ remuneration to incentivise the Related Parties and align their interests with those of the Shareholders. Alternatives may involve a cash arrangement or acquiring Shares on market.

4.5 Technical Information required by Listing Rule 10.13 and section 219 of the Corporations Act

Pursuant to and in accordance with Listing Rule 10.13 and section 219 of the Corporations Act, the following information is provided in relation to Resolutions 3 to 5:

11

4881-04/2951534_4

  • (a) the Performance Rights will be issued to the following persons:

  • (i) Mr Blair Sergeant (or his nominee) pursuant to Resolution 3;

  • (ii) Mr Gary Harvey (or his nominee) pursuant to Resolution 4; and

  • (iii) Ms Caroline Keats (or her nominee) pursuant to Resolution 5,

each of whom falls within the category set out in Listing Rule 10.11.1 by virtue of being a Director;

  • (b) the maximum number of Performance Rights to be issued to the Related Parties (being the nature of the financial benefit proposed to be given) is 3,500,000 comprising:

  • (i) 1,000,000 Performance Rights to Mr Blair Sergeant (or his nominee) pursuant to Resolution 3;

  • (ii) 1,500,000 Performance Rights to Mr Gary Harvey (or his nominee) pursuant to Resolution 4; and

  • (iii) 1,000,000 Performance Rights to Ms Caroline Keats (or her nominee) pursuant to Resolution 5,

  • (c) the milestones and vesting criteria attaching to the different classes of Performance Rights are set out in Schedule 3 and the number of Performance Rights to be issued to each Director in each respective class (as described in Schedule 3) set out in the table below:

Blair
Sergeant
Gary Harvey Caroline
Keats
Class E Performance Rights 250,000 375,000 250,000
Class F Performance Rights 250,000 375,000 250,000
Class G Performance Rights 250,000 375,000 250,000
Class H Performance Rights 250,000 375,000 250,000
  • (d) the terms and conditions of the Performance Rights are set out in Schedule 3;

  • (e) the Performance Rights will be issued no later than 1 month after the date of the Meeting (or such later date to the extent permitted by any ASX waiver or modification of the Listing Rules) and it is intended that issue of the Performance Rights will occur on the same date;

  • (f) the issue price of the Performance Rights will be nil. The Company will not receive any other consideration in respect of the issue of the Performance Rights (other than in respect of funds received on exercise of the Performance Rights);

  • (g) the purpose of the issue of the Performance Rights is to provide a performance linked incentive component in the remuneration package for the Related Parties to align the interests of the Related Parties with those of Shareholders, to motivate and reward the performance of the Related Parties in their roles as Directors and to provide a cost effective way from the Company to remunerate the Related Parties, which will

12

4881-04/2951534_4

allow the Company to spend a greater proportion of its cash reserves on its operations than it would if alternative cash forms of remuneration were given to the Related Parties;

  • (h) the Company considered cash arrangements and issuing performance shares or options as alternative forms of performance linked incentives to motivate and reward the directors. The Company has agreed to issue the Performance Rights to the Related Parties subject to Shareholder approval, as opposed to alternative forms of incentives, for the following reasons:

  • (i) the Vesting Conditions attaching to the Performance Rights will align the interests of the Related Parties with those of Shareholders;

  • (ii) the Performance Rights have an expiry date by which the Vesting Conditions are to be achieved and, if the Vesting Conditions are not achieved by that date, the Performance Rights will lapse. The benefit of the Performance Rights will only be realised in the event that the Vesting Conditions are satisfied, which are share price events consistent with increases in the value of the Company;

  • (iii) the Performance Rights are unquoted, therefore the issue of the Performance Rights has no immediate dilutionary impact on Shareholders;

  • (iv) the issue of the Performance Rights is a reasonable and appropriate method to provide cost effective remuneration as the non-cash form of this benefit will allow the Company to spend a greater proportion of its cash reserves on its operations than it would if alternative cash forms of remuneration were given to the Recipients;

  • (v) the deferred taxation benefit which is available to the Related Parties in respect of an issue of Performance Rights is also beneficial to the Company as it means the Related Parties are not required to immediately sell the Performance Rights to fund a tax liability (as would be the case in an issue of Shares where the tax liability arises upon issue of the Shares) and will instead, continue to hold an interest in the Company; and

  • (vi) it is not considered that there are any significant opportunity costs to the Company or benefits foregone by the Company in issuing the Performance Rights on the terms proposed;

  • (i) the number of Performance Rights to be issued to each of the Related Parties has been determined based upon a consideration of:

  • (i) the financial benefit that the Related Parties will obtain on satisfaction of the Vesting Conditions, which is reasonable and commensurate when compared against the significant additional value of the Company in the event that the Vesting Conditions are satisfied, compared to if the Vesting Conditions are not satisfied;

13

4881-04/2951534_4

  • (ii) current market standards and/or practices of other ASX listed companies of a similar size and stage of development to the Company;

  • (iii) the remuneration of the Related Parties;

  • (iv) incentives to attract and retain the service of the Related Parties who have appropriate knowledge and expertise, while maintaining the Company’s cash reserves; and

  • (v) the small proportion of the Company's issued capital that the Performance Rights which are proposed to be issued represent (less than 7% of issued Share capital on an undiluted basis).

The Company does not consider that there are any significant opportunity costs to the Company or benefits foregone by the Company in issuing the Performance Rights upon the terms proposed;

(j) the total remuneration package for each of the Related Parties for the previous financial year and the proposed total remuneration package for the current financial year are set out below:

Related Party Current Financial Year Previous
Financial Year
Blair Sergeant 102,7661 36,630
Gary Harvey 374,4642 37,912
Caroline Keats 73,0433 Nil4

Notes:

  1. Comprising Directors’ fees of $45,000 and share-based payments of $57,766 (including an increase of $47,325, being the value of the Performance Rights).

  2. Comprising Executive Director salary of $250,000 a superannuation payment of $25,000 and share-based payments of $99,464 (including an increase of $71,987, being the value of the Performance Rights).

  3. Comprising Directors’ fees of $25,705 and share-based payments of $47,325 (comprising an increase of $47,325, being the value of the Performance Rights).

  4. Ms Keats was appointed on 6 December 2021.

  5. (k) the value of the Performance Rights and the pricing methodology is set out in Schedule 4;

  6. (l) the Performance Rights are being issued under an offer letter with each Director which sets out the terms of the Performance Rights and is otherwise on standard terms;

  7. (m) the relevant interests of the Related Parties in securities of the Company as at the date of this Notice are set out below:

Related Party Shares1 Performance
Rights
Blair Sergeant 762,797 700,0002
Gary Harvey 55,000 2,000,0003

14

4881-04/2951534_4

Related Party Shares1 Performance
Rights
Caroline Keats 41,666 Nil

Notes:

  1. Fully paid ordinary shares in the capital of the Company (ASX: RCR).

  2. Comprising 100,000 Class A Performance Rights, 200,000 Class B Performance Rights, 200,000 Class C Performance Rights and 200,000 Class D Performance Rights.

  3. Comprising 250,000 Class A Performance Rights, 500,000 Class B Performance Rights, 750,000 Class C Performance Rights and 500,000 Class D Performance Rights.

  4. (n) if the Performance Rights issued to the Related Parties are exercised, a total of 3,500,000 Shares would be issued. This will increase the number of Shares on issue from 51,336,756 (being the total number of Shares on issue as at the date of this Notice) to 54,836,756 (assuming that no Shares are issued and no convertible securities vest or are exercised) with the effect that the shareholding of existing Shareholders would be diluted by an aggregate of 6.38%, comprising 1.82% by Mr Blair Sergeant, 2.73% by Mr Gary Harvey and 1.82% by Ms Caroline Keats;

The market price for Shares during the term of the Performance Rights would normally determine whether the Performance Rights are exercised;.

  • (o) the trading history of the Shares on ASX in the 12 months before the date of this Notice is set out below:
Price Date
Highest $0.385 7 May 2021
Lowest $0.10 28 February 2022 and 1 March 2022
Last $0.11 10 May 2022

(p) each Director has a material personal interest in the outcome of Resolutions 3 to 5 on the basis that all of the Directors (or their nominees) are to be issued Performance Rights should Resolutions 3 to 5 be passed. For this reason, the Directors do not believe that it is appropriate to make a recommendation on Resolutions 3 to 5 of this Notice; and

  • (q) the Board is not aware of any other information that is reasonably required by Shareholders to allow them to decide whether it is in the best interests of the Company to pass Resolutions 3 to 5.

15

4881-04/2951534_4

GLOSSARY

$ means Australian dollars.

ASIC means the Australian Securities & Investments Commission.

ASX means ASX Limited (ACN 008 624 691) or the financial market operated by ASX Limited, as the context requires.

Board means the current board of directors of the Company.

Business Day means Monday to Friday inclusive, except New Year’s Day, Good Friday, Easter Monday, Christmas Day, Boxing Day, and any other day that ASX declares is not a business day.

Chair means the chair of the Meeting.

Closely Related Party of a member of the Key Management Personnel means:

  • (a) a spouse or child of the member;

  • (b) a child of the member’s spouse;

  • (c) a dependent of the member or the member’s spouse;

  • (d) anyone else who is one of the member’s family and may be expected to influence the member, or be influenced by the member, in the member’s dealing with the entity;

  • (e) a company the member controls; or

  • (f) a person prescribed by the Corporations Regulations 2001 (Cth) for the purposes of the definition of ‘closely related party’ in the Corporations Act.

Company means Rincon Resources Limited (ACN 628 003 538).

Constitution means the Company’s constitution.

Corporations Act means the Corporations Act 2001 (Cth).

Directors means the current directors of the Company.

Explanatory Statement means the explanatory statement accompanying the Notice.

General Meeting or Meeting means the meeting convened by the Notice.

Key Management Personnel has the same meaning as in the accounting standards issued by the Australian Accounting Standards Board and means those persons having authority and responsibility for planning, directing and controlling the activities of the Company, or if the Company is part of a consolidated entity, of the consolidated entity, directly or indirectly, including any director (whether executive or otherwise) of the Company, or if the Company is part of a consolidated entity, of an entity within the consolidated group.

Listing Rules means the Listing Rules of ASX.

Notice or Notice of Meeting means this notice of meeting including the Explanatory Statement and the Proxy Form.

16

4881-04/2951534_4

Option means an option to acquire a Share.

Optionholder means a holder of an Option.

Proxy Form means the proxy form accompanying the Notice.

Resolutions means the resolutions set out in the Notice, or any one of them, as the context requires.

Section means a section of the Explanatory Statement.

Share means a fully paid ordinary share in the capital of the Company.

Shareholder means a registered holder of a Share.

WST means Western Standard Time as observed in Perth, Western Australia.

17

4881-04/2951534_4

SCHEDULE 1 – TERMS AND CONDITIONS OF ADVISOR OPTIONS

(a) Entitlement

Each Option entitles the holder to subscribe for one Share upon exercise of the Option.

(b) Exercise Price

Subject to paragraph (i), the amount payable upon exercise of each Option will be $0.20 ( Exercise Price )

(c)

Expiry Date

Each Option will expire at 5:00 pm (WST) on 30 March 2025 ( Expiry Date ). An Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(d)

Exercise Period

The Options are exercisable at any time on or prior to the Expiry Date ( Exercise Period ).

(e)

Notice of Exercise

The Options may be exercised during the Exercise Period by notice in writing to the Company in the manner specified on the Option certificate ( Notice of Exercise ) and payment of the Exercise Price for each Option being exercised in Australian currency by electronic funds transfer or other means of payment acceptable to the Company.

(f)

Exercise Date

A Notice of Exercise is only effective on and from the later of the date of receipt of the Notice of Exercise and the date of receipt of the payment of the Exercise Price for each Option being exercised in cleared funds ( Exercise Date ).

(g)

Timing of issue of Shares on exercise

Within five Business Days after the Exercise Date, the Company will:

  • (i) issue the number of Shares required under these terms and conditions in respect of the number of Options specified in the Notice of Exercise and for which cleared funds have been received by the Company;

  • (ii) if required, give ASX a notice that complies with section 708A(5)(e) of the Corporations Act, or, if the Company is unable to issue such a notice, lodge with ASIC a prospectus prepared in accordance with the Corporations Act and do all such things necessary to satisfy section 708A(11) of the Corporations Act to ensure that an offer for sale of the Shares does not require disclosure to investors; and

  • (iii) if admitted to the official list of ASX at the time, apply for official quotation on ASX of Shares issued pursuant to the exercise of the Options.

If a notice delivered under (g)(ii) for any reason is not effective to ensure that an offer for sale of the Shares does not require disclosure to investors, the Company

18

4881-04/2951534_4

must, no later than 20 Business Days after becoming aware of such notice being ineffective, lodge with ASIC a prospectus prepared in accordance with the Corporations Act and do all such things necessary to satisfy section 708A(11) of the Corporations Act to ensure that an offer for sale of the Shares does not require disclosure to investors.

(h) Shares issued on exercise

Shares issued on exercise of the Options rank equally with the then issued shares of the Company.

(i) Reconstruction of capital

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(j) Participation in new issues

There are no participation rights or entitlements inherent in the Options and holders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the Options without exercising the Options.

(k) Change in exercise price

An Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Option can be exercised.

(l) Transferability

The Options are transferable subject to any restriction or escrow arrangements imposed by ASX or under applicable Australian securities laws.

19

4881-04/2951534_4

SCHEDULE 2 – PERFORMANCE OPTIONS TERMS AND CONDITIONS

(a) Entitlement

Each Option entitles the holder to subscribe for one fully paid ordinary share in the Company ( Share ) upon exercise of the Option.

(b)

Exercise Price

Subject to paragraph (i), the amount payable upon exercise of each Option will be $0.20 ( Exercise Price ).

(c)

Expiry Date

Each Option will expire at 5:00 pm (WST) on the date being 3 years after the date of issue ( Expiry Date ). An Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(d)

Vesting conditions

The Options shall vest if the Company raises at least $2,000,000 of additional capital at a price of more than $0.20 per Share by 28 August 2022 ( Milestone ).

(e)

Exercise Period

Once an Option has vested, it is exercisable at any time on or prior to the Expiry Date ( Exercise Period ).

(f)

Notice of Exercise

The Options may be exercised during the Exercise Period by notice in writing to the Company in the manner specified on the Option certificate ( Notice of Exercise ) and payment of the Exercise Price for each Option being exercised in Australian currency by electronic funds transfer or other means of payment acceptable to the Company.

(g)

Exercise Date

A Notice of Exercise is only effective on and from the later of the date of receipt of the Notice of Exercise and the date of receipt of the payment of the Exercise Price for each Option being exercised in cleared funds ( Exercise Date ).

(h)

Timing of issue of Shares on exercise

Within 15 Business Days after the Exercise Date, the Company will:

  • (i) issue the number of Shares required under these terms and conditions in respect of the number of Options specified in the Notice of Exercise and for which cleared funds have been received by the Company;

  • (ii) if required, give ASX a notice that complies with section 708A(5)(e) of the Corporations Act, or, if the Company is unable to issue such a notice, lodge with ASIC a prospectus prepared in accordance with the Corporations Act and do all such things necessary to satisfy section 708A(11) of the Corporations Act to ensure that an offer for sale of the Shares does not require disclosure to investors; and

20

4881-04/2951534_4

  • (iii) if admitted to the official list of ASX at the time, apply for official quotation on ASX of Shares issued pursuant to the exercise of the Options.

If a notice delivered under (g)(g)(ii) for any reason is not effective to ensure that an offer for sale of the Shares does not require disclosure to investors, the Company must, no later than 20 Business Days after becoming aware of such notice being ineffective, lodge with ASIC a prospectus prepared in accordance with the Corporations Act and do all such things necessary to satisfy section 708A(11) of the Corporations Act to ensure that an offer for sale of the Shares does not require disclosure to investors.

(i)

Shares issued on exercise

Shares issued on exercise of the Options rank equally with the then issued shares of the Company.

(j)

Reconstruction of capital

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(k)

Participation in new issues

There are no participation rights or entitlements inherent in the Options and holders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the Options without exercising the Options.

(l)

Change in exercise price

An Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Option can be exercised.

(m) Transferability

The Options are not transferable.

21

4881-04/2951534_4

SCHEDULE 3 – TERMS AND CONDITIONS OF PERFORMANCE RIGHTS

(a) Vesting Conditions and Expiry Dates

The Performance Rights shall be subject to the following Vesting Conditions and shall have the following Vesting Periods and Expiry Dates :

Class of
Performance
Rights
Number of
Performance
Rights
Vesting Conditions Vesting
Period
Expiry Date
Class E 875,000 Company Share
price reaches at
least $0.30, based
on a 20 day VWAP
(defined below)
5 years from
the date of
grant
5 years from
the date of
grant
Class F 875,000 Company Share
price reaches at
least $0.35, based
on a 20 day VWAP
Class G 875,000 Company Share
price reaches at
least $0.40, based
on a 20 day VWAP
Class H 875,000 Company Share
price reaches at
least $0.50, based
on a 20 day VWAP
- 3,500,000 (100% of
unvested
Performance
Rights)
Upon a Change of
Control Event
(defined below)

20 day VWAP means a volume weighted average price for Shares over 20 consecutive trading days on which Shares have actually traded on ASX.

Change of Control Event means the occurrence of:

  • (i) a takeover bid under Chapter 6 of the Corporations Act 2001 (Cth) having been made in respect of the Company having received acceptances for more than 50% of the Company’s Shares on issue and being declared unconditional by the bidder; or

  • (ii) a Court granting orders approving a compromise or arrangement for the purposes of or in connection with a scheme of arrangement for the reconstruction of the Company or its amalgamation with any other company or companies.

  • (b) Notification to holder

The Company shall notify the holder in writing when the relevant Vesting Condition has been satisfied.

22

4881-04/2951534_4

(c) Conversion

Subject to paragraph (o), upon satisfaction of the applicable Vesting Condition, each Performance Right will, at the election of the holder, convert into one Share.

(d) Lapse of a Performance Rights

Any Performance Right that has not been converted into a Share prior to the Expiry Date specified in paragraph (a) will automatically lapse.

(e) Fraudulent or dishonest action

If the holder (or the person who nominated the holder to receive the Performance Rights) ceases to be an employee or Director of the Company in circumstances where the cessation or termination is specifically referenced to the holder (or such person) having been found to have acted fraudulently or dishonestly in the performance of his or her duties, then the Board must deem any Performance Rights (including any vested but unexercised Performance Rights) of the holder to have immediately lapsed and be forfeited.

(f) Ceasing to be an employee or Director

If a holder (or the person who nominated the holder to receive the Performance Rights) ceases to be an employee or Director of the Company in circumstances where the cessation or termination arises because the holder (or such person):

  • (i) voluntarily resigns his or her position (other than to take up employment with a subsidiary of the Company);

  • (ii) wilfully breaches the terms of the engagement of the holder or any policy of the Company’s published policies regulating the behaviour of holder (or such person);

  • (iii) is convicted of a criminal offence which, in the reasonable opinion of the Company, might tend to injure the reputation or the business of the Company; or

  • (iv) is found guilty of a breach of the Corporations Act and the Board considers that it brings the holder or the Company into disrepute,

then:

  • (v) unless the Board decides otherwise in its absolute discretion, will deem any Performance Rights of the holder to have immediately lapsed and be forfeited; and

  • (vi) any Performance Rights that have vested will continue in existence in accordance with their terms of issue only if the relevant Vesting Conditions have previously been met and any Shares issued on satisfaction of the applicable Vesting Conditions will remain the property of the holder.

(g)

Other circumstances

The Performance Rights will not lapse and be forfeited where the holder ceases to be an employee or Director of the Company for one of the following reasons:

23

4881-04/2951534_4

  • (i) death or total permanent disability (in respect of total permanent disability being that because of a sickness or injury, the holder is unable to work in his or her own or any occupation for which they are suited by training, education, or experience for a period beyond one year);

  • (ii) redundancy (being where the holder ceases to be an employee or Director due to the Company no longer requiring the holder’s position to be performed by any person); or

  • (iii) any other reason, other than a reason listed in rules (f) and (g) (not including (g)(i), in which case the Board may exercise its absolute discretion to allow the resigned to retain their Performance Rights), that the Board determines is reasonable to permit the holder to retain his or her Performance Rights,

and in those circumstances the Performance Rights will continue to be subject to the applicable Vesting Conditions.

(h)

Share ranking

All Shares issued upon the conversion of Performance Rights on satisfaction of the applicable Vesting Condition will upon issue rank pari passu in all respects with other Shares.

(i)

Application to ASX

The Performance Rights will not be quoted on ASX. The Company must apply for the official quotation of a Share issued on conversion of a Performance Right on ASX within the time period required by the ASX Listing Rules.

(j)

Timing of issue of Shares on Conversion

Within 10 business days after the date that Performance Rights are converted, the Company will:

  • (i) issue the number of Shares required under these terms and conditions in respect of the number of Performance Rights converted;

  • (ii) if required, give ASX a notice that complies with section 708A(5)(e) of the Corporations Act, or, if the Company is unable to issue such a notice, lodge with ASIC a prospectus prepared in accordance with the Corporations Act and do all such things necessary to satisfy section 708A(11) of the Corporations Act to ensure that an offer for sale of the Shares does not require disclosure to investors; and

  • (iii) if admitted to the official list of ASX at the time, apply for official quotation on ASX of Shares issued pursuant to the conversion of the Performance Rights.

If a notice delivered under (j)(ii) for any reason is not effective to ensure that an offer for sale of the Shares does not require disclosure to investors, the Company must, no later than 20 Business Days after becoming aware of such notice being ineffective, lodge with ASIC a prospectus prepared in accordance with the Corporations Act and do all such things necessary to satisfy section 708A(11) of the Corporations Act to ensure that an offer for sale of the Shares does not require disclosure to investors.

24

4881-04/2951534_4

(k) Transfer of Performance Rights

Upon issue the Performance Rights are not transferable.

(l) Participation in new issues

A Performance Right does not entitle a holder (in their capacity as a holder of a Performance Right) to participate in new issues of capital offered to holders of Shares such as bonus issues and entitlement issues.

(m)

Reorganisation of capital

If at any time the issued capital of the Company is reconstructed, all rights of a holder will be changed in a manner consistent with the applicable ASX Listing Rules and the Corporations Act at the time of reorganisation (including any relevant share price milestone where applicable).

(n) Dividend and voting rights

The Performance Rights do not confer on the holder an entitlement to vote (except as otherwise required by law) or receive dividends.

(o) Deferral of conversion if resulting in a prohibited acquisition of Shares

If the conversion of a Performance Right would result in any person being in contravention of section 606(1) of the Corporations Act 2001 (Cth) ( General Prohibition ) then the conversion of that Performance Right shall be deferred until such later time or times that the conversion would not result in a contravention of the General Prohibition. In assessing whether a conversion of a Performance Right would result in a contravention of the General Prohibition:

  • (i) holders may give written notification to the Company if they consider that the conversion of a Performance Right may result in the contravention of the General Prohibition. The absence of such written notification from the holder will entitle Company to assume the conversion of a Performance Right will not result in any person being in contravention of the General Prohibition;

  • (ii) the Company may (but is not obliged to) by written notice to a holder request a holder to provide the written notice referred to in paragraph (o)(i) within seven days if the Company considers that the conversion of a Performance Right may result in a contravention of the General Prohibition. The absence of such written notification from the holder will entitle the Company to assume the conversion of a Performance Right will not result in any person being in contravention of the General Prohibition.

(p) No rights to return of capital

A Performance Right does not entitle the holder to a return of capital, whether in a winding up, upon a reduction of capital or otherwise.

(q) Rights on winding up

A Performance Right does not entitle the holder to participate in the surplus profits or assets of the Company upon winding up.

25

4881-04/2951534_4

(r) No other rights

A Performance Right gives the holder no rights other than those expressly provided by these terms and those provided at law where such rights at law cannot be excluded by these terms.

26

4881-04/2951534_4

SCHEDULE 4 – VALUATION OF PERFORMANCE RIGHTS

The Performance Rights to be issued to the Related Parties pursuant to Resolutions 3 to 5 have been independently valued by Moore Australia on 6 May 2022 using a trionomial valuation model .

The estimated value of the Performance Rights has been calculated based upon the anticipated market values and based on the assumptions set out below, the Performance Rights were ascribed the following value:

Class E Class F Class G Class H
Assumptions:
Valuation date 06/05/2022 06/05/2022 06/05/2022 06/05/2022
Expiry date (length of time from
date of issue)
5 years 5 years 5 years 5 years
Share price at valuation date $0.13 $0.13 $0.13 $0.13
Provision for employee exit 16% 16% 16% 16%
Indicative value per Performance
Right
$0.0491 $0.0480 $0.0470 $0.0452
Number of performance rights 875,000 875,000 875,000 875,000
Total Value of Performance Rights $42,958 $42,018 $41,143 $39,565

Note: The valuation noted above is not necessarily the market price that the Performance Rights could be traded at and is not automatically the market price for taxation purposes.

Using the above valuations, the value of the Performance Rights being issued to each Director is set out below:

Tranche Number to be issued Total value ($)
Blair Sergeant – Performance Rights
Class E 250,000 12,274
Class F 250,000 12,005
Class G 250,000 11,755
Class H 250,000 11,304
TOTAL 47,338
Caroline Keats – Performance Rights
Class E 250,000 12,274
Class F 250,000 12,005
Class G 250,000 11,755
Class H 250,000 11,304
TOTAL 47,338

27

4881-04/2951534_4

Gary Harvey – Performance Rights Gary Harvey – Performance Rights
Class E 375,000 18,410
Class F 375,000 18,008
Class G 375,000 17,633
Class H 375,000 16,956
TOTAL 71,007

Note: The valuation noted above is not necessarily the market price that the Performance Rights could be traded at and is not automatically the market price for taxation purposes.

28

4881-04/2951534_4

PROXY FORM

29

4881-04/2951534_4

==> picture [19 x 13] intentionally omitted <==

==> picture [511 x 203] intentionally omitted <==

==> picture [201 x 12] intentionally omitted <==

==> picture [45 x 12] intentionally omitted <==

==> picture [101 x 12] intentionally omitted <==

==> picture [99 x 12] intentionally omitted <==

==> picture [46 x 12] intentionally omitted <==

==> picture [497 x 12] intentionally omitted <==

✓ ✓

==> picture [380 x 756] intentionally omitted <==

==> picture [113 x 13] intentionally omitted <==

==> picture [32 x 201] intentionally omitted <==

==> picture [33 x 11] intentionally omitted <==

==> picture [93 x 11] intentionally omitted <==

==> picture [5 x 11] intentionally omitted <==

==> picture [100 x 11] intentionally omitted <==

==> picture [59 x 12] intentionally omitted <==

==> picture [36 x 12] intentionally omitted <==

==> picture [80 x 11] intentionally omitted <==

==> picture [28 x 11] intentionally omitted <==

==> picture [19 x 12] intentionally omitted <==

==> picture [35 x 12] intentionally omitted <==

==> picture [30 x 12] intentionally omitted <==

==> picture [100 x 133] intentionally omitted <==

==> picture [114 x 10] intentionally omitted <==

==> picture [17 x 16] intentionally omitted <==

==> picture [61 x 11] intentionally omitted <==

==> picture [49 x 230] intentionally omitted <==

==> picture [109 x 11] intentionally omitted <==

/ /

==> picture [24 x 10] intentionally omitted <==